Department of Public Health, Mount Kenya University-Rwanda, Kicukiro District, Kigali, Rwanda.
Pan Afr Med J. 2022 May 17;42:45. doi: 10.11604/pamj.2022.42.45.33460. eCollection 2022.
globally, 600,000 women died of complications due to pregnancies among more than 2 million women on antiretroviral treatment who get pregnant every year due to low utilization of dual contraception and unsafe sex. The failure rate of preventing of mother-to-child transmission of HIV/AIDS (PMTCT) in Rwanda was 2% in 2019. In Rwanda, there was no research done and published on this topic. To fill the gap, the study aimed to assess the use of dual contraceptives and associated factors among women aged 15-49 years on antiretroviral (ART) in Kayonza District, Rwanda.
a cross-sectional design was conducted in October 2021. The sample was 345 participants selected by cluster simple random sampling from a targeted population of 1426 women. The interviews were conducted, and structured questionnaires were filled out before entering and analyzing data into Statistical Package Social Sciences (SPSS). Descriptive statistics analysis was used to determine frequencies and percentages, while multivariate seconded the bivariate regression analysis determine the factors associated to dual contraception by odds ratio with 95% CI.
the mean age of interviewees was 35.59 years and the majority of them were married women (60.9%). The dual contraception rate was 40%. The multivariate analysis of factors associated with dual contraception revealed that single women were most likely (AOR=38.123, 95% CI: 6.575-221.040, p<0.001) to use combinations of condoms and other methods. The odds of utilizing dual contraceptive methods were 7.347 times (AOR=7.347, 95% CI: 0.936-57.671, p=0.049) higher among women whose partners were casual laborers. Women who did not desire to have a baby were most likely (AOR=3.990, 95% CI: 1.796-8.865, p=0.001) to utilize dual contraception. The odds of utilizing dual methods were 5.634 times (AOR=5.634, 95% CI: 2.277-13.939, p<0.001) higher among women whose sexual partners did not desire a baby compared to those whose partners did. The odds of using dual methods were 1.354 times (AOR=1.354, 95% CI: 0.705-2.602) higher among women who disclosed their HIV status to their sexual partners compared to those who did not. The odds of using dual contraception were 5.526 times (AOR=5.526, 95% CI: 2.186-13.968, p<0.001) higher among women who were in HIV program for more than five years compared to those who were in the program for one year or less.
the rate of dual contraception in this area is still low according to World Health Organization (WHO) recommendation and strategies to increase it are of paramount importance to be put in place by the Ministry of Health through Rwanda Biomedical Center, health facilities and partners in terms of training, health education, availability of dual methods at the level of the health system and men involvement in family planning.
在全球范围内,由于每年有超过 200 万接受抗逆转录病毒治疗的妇女怀孕,而双避孕措施和安全性行为的利用率低,导致 60 万名妇女死于妊娠并发症。2019 年,卢旺达母婴传播艾滋病毒/艾滋病(PMTCT)的失败率为 2%。卢旺达尚未对此主题进行研究和发表。为了填补这一空白,本研究旨在评估卡永扎区 15-49 岁接受抗逆转录病毒(ART)治疗的妇女使用双重避孕措施及其相关因素。
2021 年 10 月进行了一项横断面设计。采用整群简单随机抽样方法从目标人群 1426 名妇女中抽取了 345 名参与者。在进入并将数据分析到统计软件包社会科学(SPSS)之前,进行了访谈并填写了结构化问卷。使用描述性统计分析确定频率和百分比,而多元分析则使用优势比和 95%置信区间确定与双重避孕相关的因素。
受访者的平均年龄为 35.59 岁,其中大多数是已婚妇女(60.9%)。双重避孕率为 40%。与双重避孕相关的因素的多变量分析表明,单身女性最有可能(优势比=38.123,95%置信区间:6.575-221.040,p<0.001)使用避孕套和其他方法的组合。与伴侣为临时工的女性相比,使用双重避孕方法的几率高 7.347 倍(优势比=7.347,95%置信区间:0.936-57.671,p=0.049)。不希望生育的女性最有可能(优势比=3.990,95%置信区间:1.796-8.865,p=0.001)使用双重避孕措施。与伴侣不希望生育的女性相比,希望生育的女性使用双重方法的几率高 5.634 倍(优势比=5.634,95%置信区间:2.277-13.939,p<0.001)。与伴侣希望生育的女性相比,不希望生育的女性使用双重方法的几率高 1.354 倍(优势比=1.354,95%置信区间:0.705-2.602)。与未向性伴侣透露艾滋病毒状况的女性相比,向性伴侣透露艾滋病毒状况的女性使用双重避孕措施的几率高 1.354 倍(优势比=1.354,95%置信区间:0.705-2.602)。与在艾滋病毒方案中不足一年的女性相比,在艾滋病毒方案中超过五年的女性使用双重避孕措施的几率高 5.526 倍(优势比=5.526,95%置信区间:2.186-13.968,p<0.001)。
根据世界卫生组织(WHO)的建议,该地区的双重避孕率仍然较低,卫生部通过卢旺达生物医学中心、卫生设施和合作伙伴,在培训、健康教育、在卫生系统层面提供双重方法以及男性参与计划生育方面,有必要制定提高双重避孕率的战略。